Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproate vs Lithium in Bipolar I Manic Episode
NCT00264173Phase 4Completed
- Sponsor
- Sanofi
- Start
- Feb 2004
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of valproic acid in bipolar I disorder (2 arms), sponsored by Sanofi. Primary endpoint: Young Mania Rating Scale at 12 weeks. Started Feb 2004; status: completed.
02
Drugs
valproic acid
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00264173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00264173.